Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Infinity Pharmaceuticals, Inc. (INFI)
(
)
Quote & Articles
Transcripts
Instablogs
StockTalks
Comments on articles
Cramer
Authors on INFI
Newest on INFI
J Clinton Hill
(1)
Jon Heller
(1)
Mike Havrilla
(1)
Ohad Hammer
(2)
Alan Brochstein
(5)
Most frequent on INFI
Alan Brochstein
(
5
)
Centient Biotech Investor
(
2
)
Ohad Hammer
(
2
)
Mike Havrilla
(
1
)
Jon Heller
(
1
)
Most followed on INFI
Mike Havrilla
(
1123
)
Alan Brochstein
(
533
)
J Clinton Hill
(
388
)
Ohad Hammer
(
124
)
Jon Heller
(
45
)
Most commented on INFI
Alan Brochstein
(
15
)
Ohad Hammer
(
5
)
Mike Havrilla
(
2
)
Centient Biotech Investor
(
1
)
52wk high:
52wk low:
EPS:
PE:
Dividend:
Yield:
Market Cap:
Exchange:
Articles on Infinity Pharmaceuticals, Inc. (INFI)
by
latest
|
most commented
Bright Prospects for Micromet (Part 1)
Apr 24
•
Ohad Hammer
•
MITI
,
BYERF.PK
,
INFI
•
Comment!
|
Quick Read
20 'Bathwater Babies' and 15 'Dogs with Fleas' for the Week
Apr 20
•
J Clinton Hill
•
AAWW
,
AIPC
,
AEM
•
Comment!
|
Quick Read
Navigating the Micro-Cap Biotech Minefield
Nov 23, 2008
•
Mike Havrilla
•
ARIA
,
BMY
,
ARQL
•
2 Comments
|
Quick Read
Poniard Pharmaceuticals: Platinum Rediscovered (Part II)
Jun 24, 2008
•
Ohad Hammer
•
CELG
,
EXEL
,
GSK
•
5 Comments
|
Quick Read
Cancer Stocks Hammered Once Again
Jun 26, 2007
•
Alan Brochstein
•
AFFY
,
AGEN
,
ABPI
•
7 Comments
|
Quick Read
Cancer Stocks Slide Again
Jun 18, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks Plunge Following ASCO Meeting
Jun 11, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Cancer Stocks Soar With Annual ASCO Meeting
Jun 4, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
1 Comment
|
Quick Read
Cancer Stocks on the Go: Winners and Losers
May 29, 2007
•
Alan Brochstein
•
ACEL
,
AFFY
,
ABPI
•
3 Comments
|
Quick Read
Biotech Day In Review: Osiris Stem Cells Treatment Has Unexpected Results
Feb 15, 2007
•
Centient Biotech Investor
•
BAX
,
BAYRY.PK
,
AZN
•
Comment!
|
Quick Read
Biotech Stocks Day-In-Review: Amgen Rises On Speculation Over Patent Suit
Jan 23, 2007
•
Centient Biotech Investor
•
CEGE
,
AMGN
,
AZN
•
1 Comment
|
Quick Read
With the Discovery Partners-Infinity Pharma Deal Complete, Is It Still Worth Holding Shares
Sep 18, 2006
•
Jon Heller
•
DPII
,
INFI
•
Comment!
|
Quick Read